Trial · NCT00495716
Effect of HSV-2 Suppressive Therapy on Sexual Behavior
NCT00495716, Phase 4, Terminated, University of Washington; results first posted 2020-01-29
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of HSV-2 Suppressive Therapy on Sexual Behavior. Trials, record NCT00495716. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00495716
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of HSV-2 Suppressive Therapy on Sexual Behavior
- NCT number
- NCT00495716
- Status
- Terminated
- Phases
- Phase 4
- Enrollment
- 72 participants, actual
- Lead sponsor
- University of Washington
- Conditions
- Genital Herpes
- Interventions
- acyclovir, acyclovir
- First posted
- 2007-07-03
- Last updated
- 2023-03-07
- Results first posted
- 2020-01-29
- Limitations and caveats
- Study terminated; investigator relocated and study funding ended. Results cannot be analyzed because data were not collected.
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Effect of Suppressive Antiviral Therapy on Sexual Behavior Among HSV-2 Seropositive Persons With Multiple Sexual Partners. | 1 year |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | The Effect of Suppressive Antiviral Therapy on Sexual Behavior Among HSV-2 Seropositive Persons With Multiple Sexual Partners. | 1 year | Study terminated; investigator relocated and study funding ended. Results cannot be analyzed because data were not collected. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Episodic Treatment Arm | 35 | |
| Overall Study | STARTED | Suppressive Therapy Arm | 37 | |
| Overall Study | COMPLETED | Episodic Treatment Arm | 20 | |
| Overall Study | COMPLETED | Suppressive Therapy Arm | 24 | |
| Overall Study | NOT COMPLETED | Episodic Treatment Arm | 15 | |
| Overall Study | NOT COMPLETED | Suppressive Therapy Arm | 13 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Episodic Treatment Arm | ||
| Total, all-cause mortality | Suppressive Therapy Arm | ||
| Total, other adverse events | Episodic Treatment Arm | 0 | 35 |
| Total, other adverse events | Suppressive Therapy Arm | 0 | 37 |
| Total, serious adverse events | Episodic Treatment Arm | 0 | 35 |
| Total, serious adverse events | Suppressive Therapy Arm | 0 | 37 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| K23AI071257 | Effect of Suppressive Therapy on Behavioral Determinants of HSV-2 Transmission | MARK, KAREN ELIZABETH | UNIVERSITY OF WASHINGTON | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | 2007 to 2009 |
Source NIH RePORTER
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Episodic Treatment Arm vs Suppressive Therapy Arm: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00495716
GET https://conductscience.org/api/trials/v1/NCT00495716/registered